Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease.
Kinugasa H, Nouso K, Kobayashi Y, Yasunaka T, Onishi H, Nakamura S, Shiraha H, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Miyake Y, Ikeda F, Takaki A, Kobashi H, Yamamoto K. Kinugasa H, et al. Among authors: yasunaka t. Hepatol Res. 2011 Mar;41(3):277-81. doi: 10.1111/j.1872-034X.2010.00761.x. Hepatol Res. 2011. PMID: 21338456
Autoimmune hepatitis with acute presentation in Japan.
Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Yamamoto K. Miyake Y, et al. Among authors: yasunaka t. Dig Liver Dis. 2010 Jan;42(1):51-4. doi: 10.1016/j.dld.2009.04.009. Epub 2009 May 26. Dig Liver Dis. 2010. PMID: 19473895
Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy.
Saeki I, Shimose S, Tomonari T, Ito T, Tani J, Takeuchi Y, Yoshioka N, Naito T, Takeuchi M, Kakizaki S, Hatanaka T, Sasaki K, Yasunaka T, Sakata M, Iwamoto H, Itano S, Shirono T, Tanabe N, Yamamoto T, Kanayama Y, Naganuma A, Nishina S, Otsuka M, Kobara H, Kawashima H, Takayama T, Kawaguchi T, Yamasaki T, Takami T; Hepatology InVestigator Experts in Japan (HIVE-J) Study Group. Saeki I, et al. Among authors: yasunaka t. PLoS One. 2024 Sep 25;19(9):e0311084. doi: 10.1371/journal.pone.0311084. eCollection 2024. PLoS One. 2024. PMID: 39321197 Free PMC article.
Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice.
Shimose S, Saeki I, Tomonari T, Ito T, Tani J, Takeuchi Y, Yoshioka N, Naito T, Takeuchi M, Kakizaki S, Hatanaka T, Sasaki K, Yasunaka T, Sakata M, Iwamoto H, Itano S, Shirono T, Tanabe N, Yamamoto T, Naganuma A, Nishina S, Otsuka M, Kawashima H, Takayama T, Takami T, Kawaguchi T. Shimose S, et al. Among authors: yasunaka t. Oncol Lett. 2024 Jun 25;28(2):397. doi: 10.3892/ol.2024.14530. eCollection 2024 Aug. Oncol Lett. 2024. PMID: 38979550 Free PMC article.
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
Kikuchi T, Takeuchi Y, Nouso K, Kariyama K, Kuwaki K, Toshimori J, Iwado S, Moriya A, Hagihara H, Takabatake H, Tada T, Yasunaka T, Sakata M, Sue M, Miyake N, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A, Otsuka M. Kikuchi T, et al. Among authors: yasunaka t. Liver Int. 2024 Jul;44(7):1736-1737. doi: 10.1111/liv.15964. Epub 2024 May 8. Liver Int. 2024. PMID: 38717049 No abstract available.
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.
Kikuchi T, Takeuchi Y, Nouso K, Kariyama K, Kuwaki K, Toshimori J, Iwado S, Moriya A, Hagihara H, Takabatake H, Tada T, Yasunaka T, Sakata M, Sue M, Miyake N, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A, Otsuka M. Kikuchi T, et al. Among authors: yasunaka t. Liver Int. 2024 Jun;44(6):1456-1463. doi: 10.1111/liv.15907. Epub 2024 Mar 15. Liver Int. 2024. PMID: 38488749
Abnormal fucosylation of alpha-fetoprotein in patients with nonalcoholic steatohepatitis.
Nouso K, Furubayashi Y, Kariyama K, Wakuta A, Miyake N, Inoue K, Nagai Y, Murakami S, Adachi T, Oyama A, Wada N, Takeuchi Y, Sakata M, Yasunaka T, Onishi H, Shiraha H, Takaki A, Shiota S, Yasuda S, Toyoda H, Kawanaka M, Kumada T, Okada H. Nouso K, et al. Among authors: yasunaka t. Hepatol Res. 2021 May;51(5):548-553. doi: 10.1111/hepr.13626. Epub 2021 Mar 19. Hepatol Res. 2021. PMID: 33596344
Quality of life among patients with autoimmune hepatitis in remission: A comparative study.
Takahashi A, Abe M, Yasunaka T, Arinaga-Hino T, Abe K, Takaki A, Torimura T, Zeniya M, Yoshizawea K, Kang JH, Suzuki Y, Nakamoto N, Inui A, Tanaka A, Takikawa H, Ohira H. Takahashi A, et al. Among authors: yasunaka t. Medicine (Baltimore). 2020 Oct 23;99(43):e22764. doi: 10.1097/MD.0000000000022764. Medicine (Baltimore). 2020. PMID: 33120784 Free PMC article.
82 results